@1995victoria, I added your question to both the Blood Cancer & Disorders support group as well as the Gynecologic Cancers support group. I believe this may be the research you're referring to:
- JAK2 inactivating mutations promotes endometrial cancer progression by targeting HIF-1α https://pmc.ncbi.nlm.nih.gov/articles/PMC11669642/

Is your endometrial cancer diagnosis recent? What treatment have you had or will be having?